Leaders at the FDA, HHS and elsewhere are putting guardrails around COVID-19 boosters, which could mean delayed shots or ...

An L.A. Times reader asks, 'If you don't allow placebo trials, how exactly do you certify a vaccine as "safe and effective"?' ...

Both the FDA and EMA have suspended Ixchiq’s use in older adults after post-marketing serious adverse events that include two ...

A new trial suggests a combination vaccine may offer equal or better protection against both flu and covid-19 compared to ...

Health and Human Services Secretary Robert F. Kennedy Jr. has downplayed the deadly spread and promoted a range of unproven ...

A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.

Foregone immunizations predictably have a significant impact on the incidence of infection: more than 95% of individuals must ...

The HHS will require all new vaccines to undergo placebo-controlled trials, likely slowing down approvals and decreasing access.

In response to Pete Laird Sr.’s May 2 letter opposing Senate Bill 1557 and House Bill 2254: we owe it to our communities to base public health decisions on facts, ...

Last week a letter writer here made a plea for religious exemption laws in the commonwealth that would allow parents to refuse to vaccinate their children. Among the unsubstantiated claims ...

In this video interview, Krinx Kong, chief commercial officer, Cognivia, discusses how trial design and timelines could be impacted by a potential mandate for placebo use across all vaccine trials.

An FDA committee will soon make recommendations about this fall’s Covid-19 vaccines while Novavax still awaits full FDA ...